Sign Up to like & get
recommendations!
0
Published in 2017 at "Clinical immunology"
DOI: 10.1016/j.clim.2017.01.016
Abstract: Rheumatoid arthritis (RA) is a debilitating inflammatory autoimmune disease with no known cure. Recently, we identified the immunomodulatory enzyme indoleamine-2,3-dioxygenase 2 (IDO2) as an essential mediator of autoreactive B and T cell responses driving RA.…
read more here.
Keywords:
antibody;
therapeutic antibody;
dioxygenase ido2;
indoleamine dioxygenase ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2021 at "Journal of medicinal chemistry"
DOI: 10.1021/acs.jmedchem.1c01305
Abstract: Indoleamine 2,3-dioxygenase-1 (IDO1) plays an important role in tumor immune escape. However, unsatisfactory clinical efficacies of selective IDO1 inhibitors have impeded their further development, suggesting that they do not exert sufficient antitumor effects by selectively…
read more here.
Keywords:
cancer;
ido2;
ido1 ido2;
strategy ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2022 at "Journal of medicinal chemistry"
DOI: 10.1021/acs.jmedchem.2c00263
Abstract: Indoleamine 2,3-dioxygenase 2 (IDO2), a closely related homologue of well-studied immunomodulatory enzyme IDO1, has been identified as a pathogenic mediator of inflammatory autoimmunity in preclinical models. Therapeutic targeting IDO2 in autoimmune diseases has been challenging…
read more here.
Keywords:
inhibitor;
arthritis;
ido2;
ido2 inhibitor ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2022 at "Frontiers in Immunology"
DOI: 10.3389/fimmu.2022.886225
Abstract: Indoleamine-2,3-dioxygenase (IDO)1 and IDO2 are closely related tryptophan catabolizing enzymes that have immunomodulatory properties. Although initially studied as modifiers of T cell activity, emerging evidence suggests IDO1 and IDO2 also have important roles as modulators…
read more here.
Keywords:
ido1 ido2;
ido2;
ido2 cell;
impact ido1 ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2022 at "Frontiers in Pediatrics"
DOI: 10.3389/fped.2022.846074
Abstract: Objective To determine the performance of a commercially available risk analytic tool (IDO2) to estimate the risk for SVO2 < 40% in patients admitted in cardiac intensive care unit (CICU). Methods Medical and T3 records…
read more here.
Keywords:
risk analytic;
ido2;
risk;
care ... See more keywords